Correction of Immune Response Improves Aged Fracture Healing
Correction of Immune Response Improves Aged Fracture Healing
批准号:
10266845
负责人:
Gurpreet Baht
金额:
$16.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2023-02-28
关键词:
AffectAgeBiochemicalBiomechanicsBone InjuryBone MarrowBone Marrow TransplantationBone RegenerationBone TissueBone callusCell Culture TechniquesCell physiologyCellsComplexDataDepositionElderlyFibroblastsFractureFracture HealingFutureHealthcareHematopoieticHistological TechniquesHumanImmune responseImpairmentIn VitroInflammationInflammatoryInjuryInvestigationLabelLaboratoriesMechanicsMediatingMediator of activation proteinMesenchymalMethodsMineralsModelingMorbidity - disease rateMusOperative Surgical ProceduresOsteoblastsParabiosisPhasePopulationProcessProductionProteinsProteomicsPublishingRecoveryRejuvenationResolutionSignaling MoleculeSiteStromal CellsTechniquesTestingTherapeuticTherapeutic AgentsTherapeutic InterventionTibial FracturesTimeTranscriptWorkage relatedagedbasebonebone agingbone healingcell typecohortcostdesignefficacy testinghealinghistological stainsimprovedintravenous injectionmacrophagemortalitymouse modelnegative affectnovelosteoblast differentiationosteogenicosteoporosis with pathological fracturerecruitregenerativerepairedside effectskeletal stem celltargeted treatmenttechnology/techniquetherapy developmenttissue regenerationtissue repairtransplant model
中文摘要
摘要
骨折发生在50%的人口造成显着的发病率和死亡率和成本
每年超过200亿美元的医疗保健。骨折修复是一个复杂的过程,
信号分子和细胞过程,所有这些都还没有完全确定。因素,如先进的
年龄,可能会对这一过程产生负面影响,从而损害恢复和适当的骨愈合。我们的初步数据
表明巨噬细胞被募集到幼鼠骨损伤部位创造了一个小生境,
组织修复随着年龄的增长,分泌龛的成分丢失,导致骨愈合减少。我们
先前的联体共生和骨髓移植模型以及体外细胞培养研究已经证实
年轻的巨噬细胞龛能够改善老年小鼠的骨折修复和成骨细胞分化。
值得注意的是,在这些调查中,年轻化与经典激活,亲-
炎性,M1巨噬细胞在损伤部位,但增加交替激活,再生,M2
巨噬细胞为了用治疗方法概括这些发现,我们治疗了一小群老年人,
小鼠骨折损伤后不久注射Maresin 1。相对于溶媒对照,给药小鼠显示
减少,控制损伤后的炎症,这些小鼠的骨折骨痂含有更多的矿物质。
此外,用Maresin 1处理的巨噬细胞条件培养基改善了老化的成骨细胞
分化、基质生产和矿物形成。在这里提出的工作中,我们将确定
Maresin 1治疗改善骨折愈合的机制,并确定
由巨噬细胞分泌的小生境,其改善老化的成骨细胞功能。
英文摘要
ABSTRACT
Bone fractures occur in 50% of the population causing significant morbidity and mortality and costing
more than $20 billion in health care annually. Fracture repair is a complex process that involves numerous
signaling molecules and cellular processes, all of which have not been fully identified. Factors, such as advanced
age, can negatively affect this process thereby impairing recovery and proper bone healing. Our preliminary data
indicate that macrophages recruited to the site of bone injury in young mice create a niche that leads to robust
tissue repair. With age, the constituents of the secreted niche are lost resulting in diminished bone healing. Our
previous parabiosis and bone marrow transplant models as well as in vitro cell culture studies have confirmed
that the young macrophage niche is able to improve fracture repair and osteoblast differentiation in aged mice.
Notable within these investigations, rejuvenation coincided with decreased numbers of classically activated, pro-
inflammatory, M1 macrophages at the site of injury but increased alternatively activated, regenerative, M2
macrophages. To recapitulate these findings using a therapeutic approach, we treated a small cohort of aged
mice with Maresin1 shortly after bone fracture injury. Relative to vehicle controls, treated mice displayed
decreased, control inflammation after injury and the fracture calluses from these mice contained more mineral.
Furthermore, media conditioned by macrophages treated with Maresin1 improved aged osteoblast
differentiation, matrix production, and mineral formation. Within the proposed work here we will identify the
mechanism by which Maresin1 treatment improves bone fracture healing and determine the constituents of the
niche secreted by macrophages which improves aged osteoblast function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel target in aged fracture healing
-
批准号:10798768
-
项目类别:
-
资助金额:$41.6万
-
财政年份:2023
-
负责人:Gurpreet Baht
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: